Abstract
Advances in medical technology have made intrathecal baclofen therapy a suitable treatment option for patients suffering from a variety of disorders affecting movement, especially spasticity. These patients have typically exhausted conservative therapies, usually including oral baclofen therapy which has either failed to result in clinically significant reductions in spasticity, intolerable baclofen-related side effects (i.e., sedation), or both. Intrathecal drug delivery systems for movement disorders can provide continuous infusions of baclofen for improvement in rigidity and/or spasticity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Adams MM, Hicks AL. Spasticity after spinal cord injury. Spinal Cord. 2005;43:577–86.
Albright AL, Turner M, Pattisapu JV. Best- practice surgical techniques for intrathecal baclofen therapy. J Neurosurg Pediatr. 2006;104:233–9.
Booster AL, Bennet SE, Bilsky GS, Gudesblatt M, Koebel SF, McManus M, Saulino M. Best practices for Intrathecal Baclofen therapy: screening test. Neuromodulation. 2016;91:616–22.
Boster AL, Adair RL, Gooch JL, Nelson MES, Toomer A, Urquidez J, Saulino M. Best practices for Intrathecal Baclofen therapy: dosing and long-term management. Neuromodulation. 2016;19:623–31.
Follett KA, Naumann CP. A prospective study of catheter-related complications of Intrathecal Drug delivery systems. J Pain Symptom Manag. 2000;19:209–15.
Furr-Stimming E, Boyle A, Schiess M. Spasticity and Intrathecal Baclofen. Semin Neurol. 2014;34:591–6.
Hill DR, Bowery NG. H-baclofen and H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature. 1981;290:149–52.
Knutsson E, Lindoblom U, Martensson A. Plasma and cerebrospinal fluid levels of Baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23:473–84.
Lewis KS, Mueller WM. Intrathecal Baclofen for severe spasticity secondary to spinal cord injury. Ann Pharmacother. 1993;27:767–73.
Penn RD, Kroin JS. Intrathecal Baclofen Alleviates spinal cord spasticity. Lancet. 1984;1(8385):1078.
Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg. 1987;66:181–5.
Ridley B, Rawlins PK. Intrathecal Baclofen therapy: ten steps toward best practice. J Neurosci Nurs. 2006;38:72–82.
Saulino M, Anderson DJ, Doble J, Farid R, Gul F, Konrad P, Boster A. Best practices for Intrathecal Baclofen therapy: troubleshooting. Neuromodulation. 2016;19:632–41.
Saval A, Chiodo A. Intrathecal Baclofen for spasticity management: a comparative analysis of spasticity of spinal vs. cortical origin. J Spinal Cord Med. 2010;33:16–21.
Sheean G, McGuire JR. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PM R. 2009;1:827–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Smith, S.E., Shah, B.J. (2019). IDDS for Movement Disorders. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_85
Download citation
DOI: https://doi.org/10.1007/978-3-030-12281-2_85
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12280-5
Online ISBN: 978-3-030-12281-2
eBook Packages: MedicineMedicine (R0)